Apr 23 |
Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antech
|
Apr 8 |
VNRX: VolitionRx Reports 2023 Results; Distribution of Nu.Q Vet Test Expanding; Nu.Q Discover Growing; Two Key R&D Efforts in 2024/25: 1) Breakthrough Cancer Detection Method (Capture -PCR) 2) Nu.Q NET for Sepsis
|
Mar 27 |
VolitionRx Limited (AMEX:VNRX) Q4 2023 Earnings Call Transcript
|
Mar 26 |
VolitionRx Limited (VNRX) Q4 2023 Earnings Call Transcript
|
Mar 26 |
VolitionRX reports FY results
|
Mar 25 |
VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update
|
Mar 25 |
Earnings Scheduled For March 25, 2024
|
Mar 22 |
Earnings Outlook For VolitionRX
|
Mar 21 |
VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update
|
Mar 20 |
Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan
|